In metastatic melanoma, tumor-associated NLRP3/IL-1β signaling induced expansion of MDSCs, leading to reduced NK and CD8+ T-cell activity concomitant with an increased presence of Treg cells in the primary tumors. This evidence concerns the gene CD8A and neoplasm.